Real-time enrollment status for this neuromyelitis optica spectrum disorder (nmosd) clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 10:07 AM UTC
| NCT Number | NCT06780709 |
| Recruiting Status | Recruiting |
| Condition | Neuromyelitis Optica Spectrum Disorder (NMOSD) |
| Phase | NA |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Last Updated on CT.gov | April 17, 2025 (Apr 17, 2025) |
As of July 21, 2026: Clinical trial NCT06780709 is currently recruiting participants. This na study for neuromyelitis optica spectrum disorder (nmosd) is actively seeking new participants at 1 location across the United States. The study is sponsored by Icahn School of Medicine at Mount Sinai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06780709 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06780709 was last updated Apr 17, 2025 (April 17, 2025). HelloStudys verifies this status automatically.